Evidence map›Paper›PMID 22733796›Full record

ArticleDiabetes2012

Catalase prevents maternal diabetes-induced perinatal programming via the Nrf2-HO-1 defense system.

Shiao-Ying Chang, Yun-Wen Chen, Xin-Ping Zhao, Isabelle Chenier, Stella Tran, Alexandre Sauvé, Julie R Ingelfinger, Shao-Ling Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. ATDiabetologia · 2021
    Article
  9. Article
  10. Exposure to Maternal Diabetes Mellitus Causes Renal Dopamine DHypertension (Dallas, Tex. : 1979) · 2018
    Article
  11. Article
  12. Extract ofExperimental and therapeutic medicine · 2018
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Reprogramming: A Preventive Strategy in Hypertension Focusing on the Kidney.International journal of molecular sciences · 2015
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Shiao-Ying ChangCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Hôpital Hôtel-Dieu, Université de Montréal, Montréal, Québec, Canada.
Yun-Wen Chen
Xin-Ping Zhao
Isabelle Chenier
Stella Tran
Alexandre Sauvé
Julie R Ingelfinger
Shao-Ling Zhang
Centre Hospitalier de l’Université de Montréal · CAMassachusetts General Hospital · US

Funding

Canadian Institutes of Health Research MOP115025
6 · The paper itself

Abstract

We investigated whether overexpression of catalase (CAT) in renal proximal tubular cells (RPTCs) could prevent the programming of hypertension and kidney disease in the offspring of dams with maternal diabetes. Male offspring of nondiabetic and diabetic dams from two transgenic (Tg) lines (Hoxb7-green fluorescent protein [GFP]-Tg [controls] and Hoxb7/CAT-GFP-Tg, which overexpress CAT in RPTCs) were studied from the prenatal period into adulthood. Nephrogenesis, systolic blood pressure, renal hyperfiltration, kidney injury, and reactive oxygen species (ROS) generation were assessed. Gene expression of transforming growth factor-β1 (TGF-β1), nuclear factor erythroid 2p45-related factor-2 (Nrf2), and heme oxygenase-1 (HO-1) was tested in both in vitro and in vivo studies. Renal dysmorphogenesis was observed in offspring of Hoxb7-GFP-Tg dams with severe maternal diabetes; the affected male offspring displayed higher renal ROS generation and developed hypertension and renal hyperfiltration as well as renal injury with heightened TGF-β1 expression in adulthood. These changes were ameliorated in male offspring of diabetic Hoxb7/CAT-GFP-Tg dams via the Nrf2-HO-1 defense system. CAT promoted Nrf2 nuclear translocation and HO-1 gene expression, seen in both in vitro and in vivo studies. In conclusion, CAT overexpression in the RPTCs ameliorated maternal diabetes-induced perinatal programming, mediated, at least in part, by triggering the Nrf2-HO-1 defense system.

Indexed as

AnimalsCatalaseDiabetes Mellitus, ExperimentalFemaleHeme Oxygenase-1HypertensionKidney DiseasesMaleMiceMice, TransgenicNF-E2-Related Factor 2Reactive Oxygen SpeciesCatalaseHeme Oxygenase-1Nfe2l2 protein, mouseNF-E2-Related Factor 2Reactive Oxygen Species

Identifiers

PMID22733796
PMCPMC3447903
OpenAlexW2135107467

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.